Selected Publications
Schuster, Stephen J. Huw, Ling-Yuh. Bolen, Christopher R. Maximov, Victor. Polson, Andrew G. Hatzi, Katerina. Lasater, Elisabeth A. Assouline, Sarit E. Bartlett, Nancy L. Budde, L Elizabeth. Matasar, Matthew J. Koeppen, Hartmut. Piccione, Emily C. Wilson, Deanna. Wei, Michael C. Yin, Shen. Penuel, Elicia.: Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas. Blood. : 2023.
Landsburg, Daniel J. Morrissette, Jennifer J. Nasta, Sunita D. Barta, Stefan K. Schuster, Stephen J. Svoboda, Jakub. Chong, Elise A. Bagg, Adam.: TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era. Blood Advances. 7 (23): 7243-7253,2023.
Scordo, Michael. Flynn, Jessica R. Gonen, Mithat. Devlin, Sean M. Parascondola, Allison. Tomas, Ana Alarcon. Shouval, Roni. Brower, Jamie. Porter, David L. Schuster, Stephen J. Bachanova, Veronika. Maakaron, Joseph. Maziarz, Richard T. Chen, Andy I. Nastoupil, Loretta J. McGuirk, Joseph P. Oluwole, Olalekan O. Ip, Andrew. Leslie, Lori A. Bishop, Michael R. Riedell, Peter A. Perales, Miguel-Angel.: Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma. Blood Advances. 7 (18): 2023.
Yamshon, Samuel. Chen, Gui. Gribbin, Caitlin. Christos, Paul. Shah, Bijal D. Schuster, Stephen J. Smith, Sonali M. Svoboda, Jakub. Furman, Richard R. Leonard, John P. Martin, Peter. Ruan, Jia.: Nine-year Follow-up of Lenalidomide Plus Rituximab as Initial Treatment for Mantle Cell Lymphoma. Blood Advances. : 2023.
Ang, Zhiwei. Paruzzo, Luca. Hayer, Katharina E. Schmidt, Carolin. Torres-Diz, Manuel. Xu, Feng. Zankharia, Urvi. Zhang, Yunlin. Soldan, Samantha S. Zheng, Sisi. Falkenstein, Catherine D. Loftus, Joseph Patrick. Yang, Scarlett Y. Asnani, Mukta. Sainos, Patricia King. Pillai, Vinodh. Chong, Emeline R. Li, Marilyn. Tasian, Sarah K. Barash, Yoseph. Lieberman, Paul M. Ruella, Marco. Schuster, Stephen J. Thomas-Tikhonenko, Andrei.: Alternative splicing of its 5' UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies. Blood. : 2023.
Scordo, Michael. Flynn, Jessica R. Gonen, Mithat. Devlin, Sean M. Parascondola, Allison. Tomas, Ana Alarcon. Shouval, Roni. Brower, Jamie., Porter, David L. Schuster, Stephen J. Bachanova, Veronika. Maakaron, Joseph. Maziarz, Richard T. Chen, Andy I. Nastoupil, Loretta J. McGuirk, Joseph P. Oluwole, Olalekan O. Ip, Andrew. Leslie, Lori A., Bishop, Michael R. Riedell, Peter A. Perales, Miguel-Angel.: Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma. Blood Advances. 7 (18): 5579-5585,2023.
Bhaskar, Shakthi T. Patel, Vivek G. Porter, David L. Schuster, Stephen J. Nastoupil, Loretta J. Perales, Miguel-Angel. Tomas, Ana Alarcon. Bishop, Michael R. McGuirk, Joseph P. Maziarz, Richard T. Chen, Andy I. Bachanova, Veronika. Maakaron, Joseph E. Riedell, Peter A. Oluwole, Olalekan O.: Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome. Blood Advances. 7 (17): 4765-4772,2023.
Bartlett, Nancy L. Assouline, Sarit. Giri, Pratyush. Schuster, Stephen J. Cheah, Chan Y. Matasar, Matthew. Gregory, Gareth P. Yoon, Dok Hyun. Shadman, Mazyar. Fay, Keith. Yoon, Sung-Soo. Panizo, Carlos. Flinn, Ian. Johnston, Anna. Bosch, Francesc. Sehn, Laurie H. Wei, Michael C. Yin, Shen. To, Iris. Li, Chi-Chung. Huang, Huang. Kwan, Antonia. Penuel, Elicia. Budde, Lihua E.: Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma. Blood Advances. 7 (17): 4926-4935,2023.
Landsburg, Daniel J. Nasta, Sunita D. Svoboda, Jakub. Gerson, James N. Schuster, Stephen J. Barta, Stefan K. Chong, Elise A. Difilippo, Heather. Weber, Elizabeth. Cunningham, Kathleen. Catania, Christopher. Garfall, Alfred L. Stadtmauer, Edward A. Frey, Noelle V. Porter, David L.: Survival Outcomes for Patients with Relapsed/ Refractory Aggressive B Cell Lymphomas Following Receipt of High-Dose Chemotherapy/Autologous Stem Transplantation and/or Chimeric Antigen Receptor-Modified T Cells. Transplant Cell Ther. 29 (8): 495-503,2023.
Siddiqi, Tanya. Maloney, David G. Kenderian, Saad S. Brander, Danielle M. Dorritie, Kathleen. Soumerai, Jacob. Riedell, Peter A. Shah, Nirav N. Nath, Rajneesh. Fakhri, Bita. Stephens, Deborah M. Ma, Shuo. Feldman, Tatyana. Solomon, Scott R. Schuster, Stephen J. Perna, Serena K. Tuazon, Sherilyn A. Ou, San-San. Papp, Eniko. Peiser, Leanne. Chen, Yizhe. Wierda, William G.: Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1-2 study. Lancet. 402 (10402): 641-654,2023.
View all publications
Academic Contact Information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-178
3400 Civic Center Blvd
Philadelphia,
PA
19104
Phone: 215-349-5330
Patient appointments: 800-789-7366